Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05949879 · ClinicalTrials.gov registry record · NA

Dose Response Effects of Pecan Consumption

A NA study of Overweight and Obesity and Nutrition, Healthy, sponsored by University of Georgia.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05949879: Recruiting NA study of Overweight and Obesity and Nutrition, Healthy, sponsored by University of Georgia.

NCT05949879 is a NA study of Overweight and Obesity and Nutrition, Healthy that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 80 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05949879, a NA study of Overweight and Obesity and Nutrition, Healthy, is actively recruiting participants, sponsored by University of Georgia.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain more total phenols, sterols, and flavonoids than any other tree nut. They also are a rich source of polyunsaturated fatty acids (PUFAs), fiber, vitamin A, vitamin E, folic acid, calcium, magnesium, phosphorus, potassium, and zinc. These bioactive components in pecans are likely the reason for the previously documented improvements in cardiometabolic health. The specific aims of this study are to: * Examine the effect of pecan consumption at doses of 6%, 13%, and 20% of total energy needs on fasting and postprandial blood lipids. * Examine the effect of pecan consumption at doses of 6%, 13%, and 20% of total energy needs on plasma markers associated with overall health. * Examine the effect of pecan consumption at doses of 6%, 13%, and 20% of total energy needs on subjective and physiologic postprandial measures of hunger and satiety. Participants will be asked to: * Consume pecans daily for 28 days or maintain their current habitual diet. * Attend three short weekly visits for fasting blood craws, body measurements, and collect their next week's supply of study materials. * Attend two longer (5 h) testing visits which include consuming a standard breakfast meal and having their blood drawn periodically before and after breakfast. Researchers will compare pecan LOW, pecan MID, pecan HIGH, and the Control group to examine the physiologic effects of incorporating various dosages of pecans into one's diet.

Primary Outcome

The concentration of fasting serum total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B (mg/dl).

Interventions

  • OTHER Pecan LOW
  • OTHER Pecan MID
  • OTHER Pecan HIGH
  • OTHER CONTROL

Study Locations (1)

Georgia

  • University of Georgia - Athens

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-08-01
Est. Completion 2026-08-01
Phase NA
University of Georgia

59 total trials

What NCT05949879 shows while recruiting

NCT05949879 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (65% lower).

The record links to 3 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 4 interventions - of which Pecan LOW is the first listed.

NCT05949879 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT05949879 about?

NCT05949879 is a clinical study titled "Dose Response Effects of Pecan Consumption". The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain more total phenols, sterols, and flavonoids than any other tree nut. They also are a rich source of polyunsaturated fatty acids (PUFAs), fiber, vitamin A, vitamin E, ...

What is the current status of trial NCT05949879?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-08-01. Estimated completion is 2026-08-01.

What conditions does trial NCT05949879 study?

This clinical trial studies the following conditions: Overweight and Obesity, Nutrition, Healthy, Dyslipidemias.

What interventions are being tested in trial NCT05949879?

The interventions under investigation include: Pecan LOW (OTHER), Pecan MID (OTHER), Pecan HIGH (OTHER), CONTROL (OTHER).

Who is sponsoring clinical trial NCT05949879?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05949879 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05949879's enrollment target sits among peer trials

80 62nd of 115 higher than 51 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05949879, the US trial registry maintained by the National Library of Medicine. NCT05949879 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.